Arbutus Biopharma Corporation · NASDAQ:ABUS

Morgan Stanley reported a 11.40% stake in Arbutus Biopharma Corporation (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 3, 2025

Morgan Stanley reported a 11.40% stake in Arbutus Biopharma Corporation, 21,524,661 shares, as a passive investor on Dec 31, 2024. Filed Feb 3, 2025 (Schedule 13G/A).

Stake
11.40%
Shares
21,524,661
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley11.40%21,524,661
Morgan Stanley Investment Management Inc.11.20%21,234,598

Source

View original at SEC

Related